We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CELC market cap is 367.89M. The company's latest EPS is USD -2.6352 and P/E is -5.72.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -11.64M | -12.55M | -15.06M | -18.9M | -19.73M |
| Net Income | -11.58M | -11.94M | -14.59M | -18.4M | -18.85M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.81M | -9.56M | -28.36M | -39.39M | -66.23M |
| Net Income | -7.36M | -9.47M | -29.61M | -40.37M | -63.78M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 175.7M | 164.88M | 153.52M | 142.38M | 191.22M |
| Total Liabilities | 41.93M | 41.65M | 43.39M | 49.49M | 51.45M |
| Total Equity | 133.77M | 123.23M | 110.13M | 92.9M | 139.77M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 20.28M | 12.96M | 85.91M | 175.7M | 191.22M |
| Total Liabilities | 983k | 1.26M | 17.2M | 41.93M | 51.45M |
| Total Equity | 19.3M | 11.7M | 68.71M | 133.77M | 139.77M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -36.01M | -12.87M | -22.53M | -35.28M | -53.81M |
| Investing | -144.03M | 21.87M | 29.96M | 36.21M | -5.01M |
| Financing | 120.33M | 68k | 240k | 255k | 64.91M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6M | -7.15M | -20.31M | -36.01M | -53.81M |
| Investing | 8.53M | -89k | -81k | -144.03M | -5.01M |
| Financing | 259k | 138k | 93.04M | 120.33M | 64.91M |
| Market Cap | 367.89M |
| Price to Earnings Ratio | -5.72 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 11.9 |
| Price to Book Ratio | 2.61 |
| Dividend Yield | - |
| Shares Outstanding | 24.2M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.07 (0.46%) |
| Company Name | Celcuity Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.celcuity.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
